|
2021 Journal Article Responsiveness and convergent validity of QLU-C10D and EQ-5D-3L in assessing short-term quality of life following esophagectomyBulamu, Norma B., Vissapragada, Ravi, Chen, Gang, Ratcliffe, Julie, Mudge, Louise A., Smithers, B. Mark, Isenring, Elizabeth A., Smith, Lorelle, Jamieson, Glyn G., Watson, David I., Bessell, Justin, Barbour, Andrew, Aly, Ahmad, Archer, Stephen, Ballal, Mohammed, Barbon, Jessica, Benton, Katie, Bond, Melissa, Berryman, Melissa, Bright, Tim, Cade, Richard, Cardamis, Anna, Carroll, Rosemary, Cashman, Kara, Chan, Larissa, Chapman, Brooke, Chapman, Sally, Chen, Derek, Chisholm, Jacob ... on behalf of The Australian Immunonutrition Study Group (2021). Responsiveness and convergent validity of QLU-C10D and EQ-5D-3L in assessing short-term quality of life following esophagectomy. Health and Quality of Life Outcomes, 19 (1) 233, 1-11. doi: 10.1186/s12955-021-01867-w |
|
2021 Other Outputs ctDNA as A Biomarker of Progression in Oesophageal AdenocarcinomaBonazzi, Vanessa F., Aoude, Lauren G., Brosda, Sandra, Lonie, James M., Patel, Kalpana, Bradford, Julia J., Koufariotis, Lambros T., Wood, Scott, Smithers, B. Mark, Waddell, Nicola and Barbour, Andrew P. (2021). ctDNA as A Biomarker of Progression in Oesophageal Adenocarcinoma. doi: 10.21203/rs.3.rs-1041840/v1 |
|
2021 Journal Article Characterizing the heterogeneity of small extracellular vesicle populations in multiple cancer types via an ultrasensitive chipWang, Jing, Wuethrich, Alain, Lobb, Richard J., Antaw, Fiach, Sina, Abu Ali Ibn, Lane, Rebecca E., Zhou, Quan, Zieschank, Chloe, Bell, Caroline, Bonazzi, Vanessa F., Aoude, Lauren G., Everitt, Sarah, Yeo, Belinda, Barbour, Andrew P., Möller, Andreas and Trau, Matt (2021). Characterizing the heterogeneity of small extracellular vesicle populations in multiple cancer types via an ultrasensitive chip. ACS Sensors, 6 (9) acssensors.1c00358, 3182-3194. doi: 10.1021/acssensors.1c00358 |
|
2021 Journal Article Understanding the immuno-biology of oesophageal adenocarcinoma: towards improved therapeutic approachesLonie, James M., Barbour, Andrew P. and Dolcetti, Riccardo (2021). Understanding the immuno-biology of oesophageal adenocarcinoma: towards improved therapeutic approaches. Cancer Treatment Reviews, 98 102219, 1-13. doi: 10.1016/j.ctrv.2021.102219 |
|
2021 Journal Article Australasian Gastro-Intestinal Trials Group (AGITG) MASTERPLAN: Randomized phase II study of modified neoadjuvant FOLFIRINOX alone or in combination with stereotactic radiotherapy (SBRT) for patients with high-risk and locally advanced pancreatic cancer.Oar, Andrew, Kneebone, Andrew, Lee, Mark, Goldstein, David, Sjoquist, Katrin Marie, Le, Hien, Chu, Julie, Barbour, Andrew, Gholamrezaei, Leily, Lynam, James F., Bece, Andrej, Bahamad, Sandra, Yip, Sonia, Espinoza, David, Chantrill, Lorraine A., Moore, Alisha, Lee, Dominique, Nguyen, Quoc Nam, Samra, Jaswinder and Jan.Mumford@Tics.Com.Au, No Firstname (2021). Australasian Gastro-Intestinal Trials Group (AGITG) MASTERPLAN: Randomized phase II study of modified neoadjuvant FOLFIRINOX alone or in combination with stereotactic radiotherapy (SBRT) for patients with high-risk and locally advanced pancreatic cancer.. Journal of Clinical Oncology, 39 (15_suppl). doi: 10.1200/jco.2021.39.15_suppl.tps4172 |
|
2021 Journal Article Radiomics biomarkers correlate with CD8 expression and predict immune signatures in melanoma patientsAoude, Lauren G., Wong, Bernadette, Bonazzi, Vanessa F, Brosda, Sandra, Walters, Shaun B., Koufariotis, Lambros T., Naeini, Marjan M., Pearson, John V, Oey, Harald, Patel, Kalpana, Bradford, Julia J., Bloxham, Conor J, Atkinson, Victoria, Law, Phillip, Strutton, Geoffrey, Bayley, Gerard, Yang, Samuel, Smithers, B. Mark, Waddell, Nicola, Miles, Kenneth and Barbour, Andrew P. (2021). Radiomics biomarkers correlate with CD8 expression and predict immune signatures in melanoma patients. Molecular Cancer Research, 19 (6) molcanres.1038.2020, 950-956. doi: 10.1158/1541-7786.mcr-20-1038 |
|
2021 Journal Article Human CD141+ dendritic cells (cDC1) are impaired in patients with advanced melanoma but can be targeted to enhance anti-PD-1 in a humanized mouse modelLee, Yoke Seng, O'Brien, Liam J., Walpole, Carina M., Pearson, Frances E., Leal-Rojas, Ingrid M., Masterman, Kelly-Anne, Atkinson, Victoria, Barbour, Andrew and Radford, Kristen J. (2021). Human CD141+ dendritic cells (cDC1) are impaired in patients with advanced melanoma but can be targeted to enhance anti-PD-1 in a humanized mouse model. Journal for ImmunoTherapy of Cancer, 9 (3) e001963, 1-12. doi: 10.1136/jitc-2020-001963 |
|
2021 Journal Article Complications and survival after hybrid and fully minimally invasive oesophagectomyVeenstra, M. M. K., Smithers, B. M., Visser, E., Edholm, D., Brosda, S., Thomas, J. M., Gotley, D. C., Thomson, I. G., Wijnhoven, B. P. L. and Barbour, A. P. (2021). Complications and survival after hybrid and fully minimally invasive oesophagectomy. BJS Open, 5 (1) zraa033, 1-7. doi: 10.1093/bjsopen/zraa033 |
|
2021 Journal Article Targeting DNA damage response and replication stress in pancreatic cancerDreyer, Stephan B., Upstill-Goddard, Rosie, Paulus-Hock, Viola, Paris, Clara, Lampraki, Eirini-Maria, Dray, Eloise, Serrels, Bryan, Caligiuri, Giuseppina, Rebus, Selma, Plenker, Dennis, Galluzzo, Zachary, Brunton, Holly, Cunningham, Richard, Tesson, Mathias, Nourse, Craig, Bailey, Ulla-Maja, Jones, Marc D., Moran-Jones, Kim, Wright, Derek W., Duthie, Fraser, Oien, Karin, Evers, Lisa, McKay, Colin J., McGregor, Grant A., Gulati, Aditi, Brough, Rachel, Bajrami, Ilirjana, Pettitt, Stephan, Dziubinski, Michele L. ... Sansom, Owen J. (2021). Targeting DNA damage response and replication stress in pancreatic cancer. Gastroenterology, 160 (1), 362-377.e13. doi: 10.1053/j.gastro.2020.09.043 |
|
2020 Journal Article Clinical pathways and outcomes of patients with Barrett’s esophagus in tertiary care settings: a prospective longitudinal cohort study in Australia, 2008–2016Na, Renhua, Miura, Kyoko, O’Brien, Suzanne, Eslick, Guy D., Kendall, Bradley J., Hourigan, Luke F., Bourke, Michael, Cox, Michael R., Farrokhzadi, Laal, Levert-Mignon, Angelique J., Barbour, Andrew P., Clemons, Nicholas J., Duong, Cuong P., Lord, Reginald V., Phillips, Wayne A., Watson, David I. and Whiteman, David C. (2020). Clinical pathways and outcomes of patients with Barrett’s esophagus in tertiary care settings: a prospective longitudinal cohort study in Australia, 2008–2016. Diseases of the Esophagus, 34 (8) doaa119. doi: 10.1093/dote/doaa119 |
|
2020 Journal Article Sex differences in oncogenic mutational processesLi, Constance H., Prokopec, Stephenie D., Sun, Ren X., Yousif, Fouad, Schmitz, Nathaniel, Al-Shahrour, Fatima, Atwal, Gurnit, Bailey, Peter J., Biankin, Andrew V., Boutros, Paul C., Campbell, Peter J., Chang, David K., Cooke, Susanna L., Deshpande, Vikram, Faltas, Bishoy M., Faquin, William C., Garraway, Levi, Getz, Gad, Grimmond, Sean M., Haider, Syed, Hoadley, Katherine A., Jiao, Wei, Kaiser, Vera B., Karlić, Rosa, Kato, Mamoru, Kübler, Kirsten, Lazar, Alexander J., Li, Constance H., Louis, David N. ... Lakhani, Sunil R. (2020). Sex differences in oncogenic mutational processes. Nature Communications, 11 (1) 4330. doi: 10.1038/s41467-020-17359-2 |
|
2020 Journal Article Divergent mutational processes distinguish hypoxic and normoxic tumoursBhandari, Vinayak, Li, Constance H., Bristow, Robert G., Boutros, Paul C., Aaltonen, Lauri A., Abascal, Federico, Abeshouse, Adam, Aburatani, Hiroyuki, Adams, David J., Agrawal, Nishant, Ahn, Keun Soo, Ahn, Sung-Min, Aikata, Hiroshi, Akbani, Rehan, Akdemir, Kadir C., Al-Ahmadie, Hikmat, Al-Sedairy, Sultan T., Al-Shahrour, Fatima, Alawi, Malik, Albert, Monique, Aldape, Kenneth, Alexandrov, Ludmil B., Ally, Adrian, Alsop, Kathryn, Alvarez, Eva G., Amary, Fernanda, Amin, Samirkumar B., Aminou, Brice, Ammerpohl, Ole ... PCAWG Consortium (2020). Divergent mutational processes distinguish hypoxic and normoxic tumours. Nature Communications, 11 (1) 737. doi: 10.1038/s41467-019-14052-x |
|
2020 Journal Article Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samplesBailey, Matthew H., Meyerson, William U., Dursi, Lewis Jonathan, Wang, Liang-Bo, Dong, Guanlan, Liang, Wen-Wei, Weerasinghe, Amila, Li, Shantao, Kelso, Sean, Akbani, Rehan, Anur, Pavana, Bailey, Matthew H., Buchanan, Alex, Chiotti, Kami, Covington, Kyle, Creason, Allison, Ding, Li, Ellrott, Kyle, Fan, Yu, Foltz, Steven, Getz, Gad, Hale, Walker, Haussler, David, Hess, Julian M., Hutter, Carolyn M., Kandoth, Cyriac, Kasaian, Katayoon, Kasapi, Melpomeni, Larson, Dave ... von Mering, Christian (2020). Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples. Nature Communications, 11 (1) 4748. doi: 10.1038/s41467-020-18151-y |
|
2020 Journal Article Author Correction: Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples (Nature Communications, (2020), 11, 1, (4748), 10.1038/s41467-020-18151-y)Bailey, Matthew H., Meyerson, William U., Dursi, Lewis Jonathan, Wang, Liang-Bo, Dong, Guanlan, Liang, Wen-Wei, Weerasinghe, Amila, Li, Shantao, Li, Yize, Kelso, Sean, Akbani, Rehan, Anur, Pavana, Bailey, Matthew H., Buchanan, Alex, Chiotti, Kami, Covington, Kyle, Creason, Allison, Ding, Li, Ellrott, Kyle, Fan, Yu, Foltz, Steven, Getz, Gad, Hale, Walker, Haussler, David, Hess, Julian M., Hutter, Carolyn M., Kandoth, Cyriac, Kasaian, Katayoon, Kasapi, Melpomeni ... von Mering, Christian (2020). Author Correction: Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples (Nature Communications, (2020), 11, 1, (4748), 10.1038/s41467-020-18151-y). Nature Communications, 11 (1) 6232. doi: 10.1038/s41467-020-20128-w |
|
2020 Journal Article Reconstructing evolutionary trajectories of mutation signature activities in cancer using TrackSigRubanova, Yulia, Shi, Ruian, Harrigan, Caitlin F., Li, Roujia, Wintersinger, Jeff, Sahin, Nil, Deshwar, Amit G., Dentro, Stefan C., Leshchiner, Ignaty, Gerstung, Moritz, Jolly, Clemency, Haase, Kerstin, Tarabichi, Maxime, Wintersinger, Jeff, Deshwar, Amit G., Yu, Kaixian, Gonzalez, Santiago, Rubanova, Yulia, Macintyre, Geoff, Adams, David J., Anur, Pavana, Beroukhim, Rameen, Boutros, Paul C., Bowtell, David D., Campbell, Peter J., Cao, Shaolong, Christie, Elizabeth L., Cmero, Marek, Cun, Yupeng ... PCAWG Consortium (2020). Reconstructing evolutionary trajectories of mutation signature activities in cancer using TrackSig. Nature Communications, 11 (1) 731, 1-12. doi: 10.1038/s41467-020-14352-7 |
|
2020 Journal Article A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patternsJiao, Wei, Atwal, Gurnit, Polak, Paz, Karlic, Rosa, Cuppen, Edwin, Al-Shahrour, Fatima, Atwal, Gurnit, Bailey, Peter J., Biankin, Andrew V., Boutros, Paul C., Campbell, Peter J., Chang, David K., Cooke, Susanna L., Deshpande, Vikram, Faltas, Bishoy M., Faquin, William C., Garraway, Levi, Getz, Gad, Grimmond, Sean M., Haider, Syed, Hoadley, Katherine A., Jiao, Wei, Kaiser, Vera B., Karlic, Rosa, Kato, Mamoru, Kübler, Kirsten, Lazar, Alexander J., Li, Constance H., Louis, David N. ... PCAWG Consortium (2020). A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns. Nature Communications, 11 (1) 728. doi: 10.1038/s41467-019-13825-8 |
|
2020 Conference Publication Tracking genomic and transcriptomic features of oesophageal adenocarcinoma for improving patients outcomeNaeini, Marjan, Newell, Felicity, Aoude, Lauren G., Bonazzi, Vanessa F., Patel, Kalpana, Koufariotis, Lambros T., Johnson, Rebecca, Addala, Venkateswar, Kondrashova, Olga, Holmes, Oliver, Leonard, Conrad, Wood, Scott, Xu, Christina, Nones, Katia, Pearson, John V., Smithers, Mark, Watson, David, Simes, John, Price, Tim, Gebski, Val, Barbour, Andrew P. and Waddell, Nic (2020). Tracking genomic and transcriptomic features of oesophageal adenocarcinoma for improving patients outcome. HOBOKEN: WILEY. |
|
2020 Journal Article Pathogenic germline variants are associated with poor survival in stage III/IV melanoma patientsAoude, Lauren G., Bonazzi, Vanessa F., Brosda, Sandra, Patel, Kalpana, Koufariotis, Lambros T., Oey, Harald, Nones, Katia, Wood, Scott, Pearson, John V., Lonie, James M., Arneil, Melissa, Atkinson, Victoria, Smithers, B. Mark, Waddell, Nicola and Barbour, Andrew P. (2020). Pathogenic germline variants are associated with poor survival in stage III/IV melanoma patients. Scientific Reports, 10 (1) 17687, 17687. doi: 10.1038/s41598-020-74956-3 |
|
2020 Journal Article Factors predicting toxicity and response following isolated limb infusion for melanoma: an international multi-centre studyKenyon-Smith, Timothy J., Kroon, Hidde M., Miura, John T., Teras, Jüri, Beasley, Georgia M., Mullen, Dean, Farrow, Norma E., Mosca, Paul J., Lowe, Michael C., Farley, Clara R., Potdar, Aishwarya, Daou, Hala, Sun, James, Farma, Jeffrey M., Henderson, Michael A., Speakman, David, Serpell, Jonathan, Delman, Keith A., Smithers, B. Mark, Barbour, Andrew, Coventry, Brendon J., Tyler, Douglas S., Zager, Jonathan S. and Thompson, John F. (2020). Factors predicting toxicity and response following isolated limb infusion for melanoma: an international multi-centre study. European Journal of Surgical Oncology, 46 (11), 2140-2146. doi: 10.1016/j.ejso.2020.06.040 |
|
2020 Journal Article HNF4A and GATA6 Loss Reveals Therapeutically Actionable Subtypes in Pancreatic CancerBrunton, Holly, Caligiuri, Giuseppina, Cunningham, Richard, Upstill-Goddard, Rosie, Bailey, Ulla-Maja, Garner, Ian M., Nourse, Craig, Dreyer, Stephan, Jones, Marc, Moran-Jones, Kim, Wright, Derek W., Paulus-Hock, Viola, Nixon, Colin, Thomson, Gemma, Jamieson, Nigel B., McGregor, Grant A., Evers, Lisa, McKay, Colin J., Gulati, Aditi, Brough, Rachel, Bajrami, Ilirjana, Pettitt, Stephen J., Dziubinski, Michele L., Barry, Simon T., Grützmann, Robert, Brown, Robert, Curry, Edward, Allison, Sarah, Biankin, Andrew V. ... Australian Pancreatic Cancer Genome Initiative (2020). HNF4A and GATA6 Loss Reveals Therapeutically Actionable Subtypes in Pancreatic Cancer. Cell Reports, 31 (6) 107625, 1-28. doi: 10.1016/j.celrep.2020.107625 |
